Where to use Dycem in pharma & Biotech
Entry and Exit to Cleanrooms.
Hallways in-between products and processes.
Inside airlocks and product transfer areas.
Contamination: The Risk to Pharma & Biotech
Because of the highly critical nature of certain products, Good Manufacturing Practices (GMP) were developed and implemented as a system to ensure consistency and control in quality standards. A major aspect within the principles of GMP guidelines is a focus on cleanliness of facilities and equipment to prevent contamination. A robust contamination control strategy ensures products are of the highest quality, meet regulatory requirements by the Federal Drug Administration (FDA) and other governing bodies, and do not compromise the health & safety of end users. During the manufacturing process, contamination can be introduced from facility personnel, raw materials, equipment, and processes.
Common types of contamination found throughout the manufacture of drugs and biologics include visible particles like dust, debris, hair, and fibers as well as invisible particles such as skin cells, cosmetics, and microbes. The outcomes of a contamination occurrence include threats to health & safety, quarantined batches, product recalls, and factory shutdowns.
The risks to a company’s brand, their profitability, and their people are too consequential to be ignored. Effective contamination control is essential for facilities adhering to GMP guidelines.
Dycem mats, implemented as part of a contamination control strategy, offer optimal support in reducing the risk of contamination in the Pharma & Biotech industry.
Don't Ignore the Floor...
80% of Contamination Enters a Critical Space at Floor Level.
Benefits of Dycem in the Pharma & Biotech Industry
80% of contamination enters a critical space at floor level.
superior Particle collection & retention
Both visible and invisible particulates from shoes and wheels are captured on Dycem mats and remain on the surface until cleaned off. Environmental monitoring (EM) counts within cleanrooms and controlled areas are significantly reduced by up to 99%.
Reduced microbial contamination concerns
With Dycem mats installed prior to critical areas, our Pharma & Biotech customers have peace of mind that damage from microbial contamination is minimized. All Dycem products contain Polygiene Biomaster, and active anti-microbial additive.
cost effective, sustainable alternative
Unlike disposable contamination control solutions, Dycem mats last on average 3-5 years. Pharma & Biotech manufacturers typically see an ROI shortly after purchase, as well as the added benefit of a reduced carbon footprint due to less plastic waste.
Our Products, Your Industry
From the initial stages of API production, milling, and granulation, all the way through to tablet pressing, fill & finish, and sterile packaging, it is absolutely crucial to maintain high standards of quality and cleanliness at every step of drug and biologic production. Dycem’s highly effective contamination control solutions support the many complex products and processes in the Pharma & Biotech industry. Keeping contamination out of critical spaces and cleanrooms is our priority.
Cleazone helps control contamination from the shoes of personnel.
WorkZone is the only effective solution for decontamination of heavy wheels.
Other Dycem Solutions
Our products for contamination control meet the varying demands of the industry.
Discover our success stories in your industry.
Learn how our customers have benefitted from installing Dycem.
Structuring your Contamination Control Strategy
Read the following article from Dr. Tim Sandle and RSSL.
“A contamination control strategy (CCS) is a system that considers all the integral elements of pharmaceutical product manufacturing. A CCS should cover:
- Microbial contamination
- Cleaning and disinfection
- Sterility assurance
- Facility design
- Chemical and particle contamination
- Other forms of contamination that can arise from mix-ups, damaging primary or secondary packaging, distribution problems, and environmental fluctuations”